Miramoon Pharma Analysis

First in class drugs for neurodegenerative diseases

Developing treatments for Retinitis Pigmentosa; Researching drugs for Duchenne Muscular Dystrophy; Creating therapies for Amyotrophic Lateral Sclerosis; Innovating solutions for rare diseases; Advancing neurodegenerative disease research.

Solid intellectual property position with patents in key markets; Supported by a high-level advisory board; Experienced management team in neurodegenerative disease research.

Main Information

• Information: MIRAMON PHARMA: more company information coming soon.
• Interests: Not available.
• Location: Hall 8.1 - 4YFN Stand 8.1B11
• Whether tagged as startup: Not available.

Contact & Links

• LinkedIn: Not available.
• Twitter: Not available.
• Phone Number: Not available.
• Email: Not available.

Key Information

• Growth Stage: Not available.
• Country: Not available.
• Founding Year: Not available.

Company Context

Company Name: Miramon Pharma; Company Website: https://www.miramoonpharma.com